Scott McNeil, NIH
|
Scott McNeil, Ph.D., is Director of the Nanotechnology Characterization Laboratory (NCL) for the National Cancer Institute at Frederick (NCI-Frederick). The NCL performs and standardizes preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics. The NCL provides infrastructure support to NCI’s Alliance in Nanotechnology, and is a national resource available to investigators in academia, government, and industry, to aid in the translation of nanotech cancer therapeutics into clinical applications. Prior to joining NCI-Frederick (i.e. SAIC-Frederick), he served for three years as Senior Scientist in the Nanotech Initiatives Division at SAIC where he transitioned basic nanotechnology research to government and commercial markets. Dr. McNeil received his bachelor's degree in chemistry from Portland State University and his doctorate in cell biology from Oregon Health Sciences University. His professional career includes tenure as an Army Officer, with tours as Chief of Biochemistry at Tripler Army Medical Center, as a Combat Arms officer in the Gulf War. He is an invited speaker to numerous nanotechnology-related conferences and has six patents pending related to nanotechnology and biotechnology. Dr. McNeil’s research involves coordination of pre-clinical characterization of nanomaterials intended for cancer therapeutics and diagnostics. He advises Industry and State and US Governments on the development of nanotechnology and is a member of several governmental and industrial working groups related to nanotechnology policy, standardization and commercialization. Stern ST, Zolnik BS, McLeland CB, Clogston J, Zheng J, McNeil SE. Induction of Autophagy in Porcine Kidney Cells by Quantum Dots: A Common Cellular Response to Nanomaterials? Tox Sci. 2008 [Epub ahead of print]. Dobrovolskaia MA, McNeil SE. Immunological Properties of Engineered Nanomaterials. Nature Nanotechnology 2007 2, 469-478. Chan KC, Patri AK, Veenstra TD, McNeil SE, Issaq HJ. Analysis of Fullerene-based Nanomaterial in Serum Matrix by CE. Electrophoresis 2007 28, 1518–1524. |
|
|
 |
 |
